Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million financing
Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million…
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash…
AI in Healthcare and Digital Health Today—April 20, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: 10x Genomics launches Atera Platform
Lucid Diligence Brief: 10x Genomics launches Atera Platform Professional…
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J…
Lucid Diligence Brief: STORM Therapeutics $56 million Series C for Phase II in Sarcoma
Lucid Diligence Brief: STORM Therapeutics $56 million Series C for Phase II in…
Lucid Diligence Brief: Vir Biotechnology $1.37B collaboration with Astellas
Lucid Diligence Brief: Vir Biotechnology $1.37B collaboration with Astellas…
Lucid Diligence Brief: Beeline Medicines debuts with $300M Series A
Lucid Diligence Brief: Beeline Medicines debuts with $300M Series A…
Lucid Diligence Brief: Telix / Regeneron radiopharma collaboration
Lucid Diligence Brief: Telix / Regeneron radiopharma collaboration Professional…
Lucid Diligence Brief: Anthropic acquires Coefficient Bio
Lucid Diligence Brief: Anthropic acquires Coefficient Bio Professional…
AI in Healthcare and Digital Health Today—April 6, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: Insight Health $11 million Series A to focus on AI clinical agents
Lucid Diligence Brief: Insight Health $11 million Series A to focus on AI…